Quantum-Si Announced A Collaboration With Nvidia To Develop Its New Proteomics Platform, Proteus, And Advance Quantum-Si's Core Technologies Of Amino Acid Binders And Aminopeptidases Using Nvidia AI And Accelerated Computing

-3.27%

-7.86%

NVIDIA Corporation

NVDA

175.02

-3.27%

Quantum-Si Incorporated - Class A Common Stock

QSI

1.29

-7.86%

This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leveraging NVIDIA accelerated computing and Quantum-Si's advanced single-molecule protein sequencing and detection technologies, the collaboration aims to develop a robust data processing system. This system will keep pace with Quantum-Si's rapidly evolving technology advancements, generating single-molecule protein insights to deepen our understanding of the proteome and develop innovative solutions through research, drug discovery, and healthcare AI.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.